Dr Agarwals Eye Hospital Limited

Healthcare · Healthcare Services

NSE: DRAGARWQ BSE: 526783

₹5215.00

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Healthcare Services

The largest companies in the same industry by market cap. This company ranks #26 of 62. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Apollo Hospitals Enterprise Limited	114,812	73.1	20.1%	4.2%	—	73	0	27
Max Healthcare Institute Limited	89,246	124.3	13.4%	-19.5%	0.22%	77	0	26
Fortis Healthcare Limited	57,664	255.5	10.5%	-27.5%	0.13%	49	26	6
Global Health Limited	35,830	74.4	13.9%	-2.5%	0.04%	74	0	30
Aster DM Quality Care Limited	35,828	205.8	8.8%	2.8%	0.43%	53	0	26
Narayana Hrudayalaya Ltd.	35,199	61.9	17.8%	-3.7%	0.26%	66	0	29
Dr. Lal Path Labs Ltd.	33,046	38.4	20.1%	-38.0%	0.99%	82	0	88
Krishna Institute of Medical Sciences Limited	29,629	105.1	9.5%	-2.3%	—	47	0	29
Dr Agarwals Eye Hospital Limited (this stock)	2,520	32.8	20.2%	—	0.08%	81	35	21

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹2,595 Cr

EV / EBITDA

16.4x

EV / Sales

5.22x

Market cap / Sales

5.07x

Earnings yield

3.04%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 145 Cr, up 23.1% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 23 Cr, up 35.5% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	143	31	23	₹48.3800
March 31, 2026	120	21	16	₹33.6000
Dec. 31, 2025	116	23	17	₹35.7600
Sept. 30, 2025	118	26	19	₹41.0400
June 30, 2025	117	23	17	₹36.7200
March 31, 2025	100	19	16	₹34.0200
Dec. 31, 2024	95	14	10	₹22.1300
Sept. 30, 2024	102	19	14	₹30.1060
June 30, 2024	100	19	14	₹30.0200
March 31, 2024	81	17	13	₹27.2100
Dec. 31, 2023	76	13	9	₹20.0900
Sept. 30, 2023	83	17	13	₹26.7870
June 30, 2023	78	16	12	₹24.5500

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	145	122	119	118	118	100	97	104	100	83	77	86	79
Operating revenue	143	120	116	118	117	100	95	102	100	81	76	83	78
Other income	2	2	3	1	1	0	2	2	0	2	1	2	1
Operating expenses	100	86	82	78	80	68	69	72	69	56	55	61	56
Operating profit	43	34	34	40	37	32	26	30	31	24	20	22	22
Operating profit margin	30.3%	28.1%	29.6%	34.0%	31.8%	31.6%	26.9%	29.2%	31.4%	30.3%	27.1%	26.9%	28.1%
Depreciation	11	12	12	11	11	10	10	9	10	8	7	6	6
Interest	3	2	2	4	4	3	4	4	3	2	2	2	2
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	31	21	23	26	23	19	14	19	19	17	13	17	16
Tax	8	5	6	6	6	3	4	5	5	5	3	4	4
Net profit	23	16	17	19	17	16	10	14	14	13	9	13	12
EPS	48.38	33.60	35.76	41.04	36.72	34.02	22.13	30.11	30.02	27.21	20.09	26.79	24.55
Net profit (TTM)	76	70	70	63	58	55	51	50	49	46	47	43	39
EPS (TTM)	158.78	147.12	147.54	133.91	122.98	116.28	109.47	107.43	104.11	98.64	100.54	91.21	83.73

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	20.9%	27.7%	477^†	402^†	324^†	270^†	202^†	141^†	179^†	172^†	156^†	149^†
Operating revenue	20.7%	27.5%	471^†	397^†	317^†	268^†	201^†	140^†	176^†	170^†	153^†	149^†
Other income	—	—	6^†	5^†	7^†	2^†	1^†	1^†	3^†	2^†	2^†	0^†
Operating expenses	—	—	326^†	279^†	228^†	193^†	144^†	109^†	130^†	141^†	130^†	—
Operating profit	24.8%	36.8%	145^†	118^†	89^†	75^†	58^†	30^†	46^†	29^†	23^†	—
Operating profit margin	—	—	30.9%^†	29.8%^†	28.1%^†	27.9%^†	28.7%^†	21.7%^†	26.3%^†	17.0%^†	15.3%^†	—
Depreciation	—	—	46^†	39^†	27^†	20^†	20^†	19^†	21^†	11^†	10^†	—
Interest	—	—	12^†	13^†	7^†	7^†	6^†	6^†	8^†	3^†	3^†	3^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	23.7%	74.8%	94^†	71^†	62^†	49^†	32^†	6^†	20^†	17^†	13^†	10^†
Tax	—	—	24^†	16^†	16^†	12^†	8^†	7^†	6^†	6^†	7^†	3^†
Net profit	23.8%	—	70^†	55^†	46^†	37^†	24^†	-1^†	14^†	12^†	7^†	7^†
EPS	23.3%	—	147.12^†	116.28^†	98.64^†	78.56^†	51.29^†	-3.06^†	29.11^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	30.9%^†	29.8%^†	28.1%^†	27.9%^†	28.7%^†	21.7%^†	26.3%^†	17.0%^†	15.3%^†	—
EBIT margin	22.4%^†	21.2%^†	21.9%^†	21.0%^†	19.2%^†	8.6%^†	15.7%^†	11.8%^†	10.4%^†	8.8%^†
PBT margin	19.9%^†	17.8%^†	19.6%^†	18.4%^†	16.1%^†	4.1%^†	11.3%^†	10.2%^†	8.7%^†	6.6%^†
Net margin	14.9%^†	13.8%^†	14.6%^†	13.8%^†	12.0%^†	-1.0%^†	7.8%^†	7.0%^†	4.4%^†	4.4%^†
Interest coverage	8.88x^†	6.26x^†	9.68x^†	8.19x^†	6.18x^†	1.90x^†	3.59x^†	7.75x^†	6.16x^†	4.00x^†
Dividend payout	0.0%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	—	0.0%^†	—	—	—
Earnings retention	100.0%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	—	100.0%^†	—	—	—
Current ratio	1.23x	0.64x	—	—	—	—	—	—	—	—
Quick ratio	1.10x	0.49x	—	—	—	—	—	—	—	—
Debt to equity	0.24x	0.46x	—	—	—	—	—	—	—	—
Return on equity	20.2%^†	26.1%^†	—	—	—	—	—	—	—	—
Return on assets	9.1%^†	8.9%^†	—	—	—	—	—	—	—	—
Return on capital employed	16.1%^†	16.0%^†	—	—	—	—	—	—	—	—
Asset turnover	0.61x^†	0.65x^†	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	145	-174	25	98	47
March 31, 2025	94	-133	17	101	-7

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	766	346	341	15	67	137	111	7	375	14
March 31, 2025	613	210	205	15	82	56	87	11	160	13

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.